The Cost of Prescription Patent Abuse

This project will translate common prescription drug patent abuses into consumer-friendly mini-reports. Each report will focus on one example of a seminal case or regulatory action that highlights how drug companies use the patent system to delay biosimilars and generics from entering the market. Each report will have a discrete theme and include an explanation of the case and anticompetitive behavior, the impact of the delay on consumer finances and health, patient stories (as available) to further humanize the story, and visual content in a shareable format. Dissemination of the products are a vital part of the project, and each report will be accompanied by blog posts, op-eds, media outreach, grassroots engagement, and outreach to policymakers and regulators.